Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2004
04/07/2004EP1150991B1 Compositions for treating inflammatory response
04/07/2004EP1105401B1 Phosphoglycolipid and methods for its use
04/07/2004EP1028753B1 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels
04/07/2004EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
04/07/2004EP0971687B1 Aqueous solutions of salicylic acid derivatives
04/07/2004CN1487939A Amido ether substituted imidazoquinolines
04/07/2004CN1487933A Pyrazole compounds useful as protein kinase inhibitors
04/07/2004CN1487835A Composition of hypochlorous acid and its applications
04/07/2004CN1487822A Anti-adiposis composition based on garlic bulb extracts
04/07/2004CN1487082A Depilation related gene and its application
04/07/2004CN1486726A Liquid medicine for treating psoriasis and its prepn
04/07/2004CN1486722A Spot-eliminating Chinese medicine with the functions of dispersing the stagnated liver energg and eliminating depressive syndrome
04/07/2004CN1486720A Lotion for treating beriberi and tinea pedis
04/07/2004CN1486716A Chinese medicine for treating leukoderma and the prepn process of the tablets
04/07/2004CN1486713A Burn treating medicine
04/07/2004CN1486702A Injection for eliminating wrinkles and scar and its prepn
04/07/2004CN1486697A Cream for treating keratosis and chap
04/07/2004CN1486684A Herbal acne-eliminating cream
04/07/2004CN1144813C Noval pregnane derivatives without substituting group at 17šŒlpha position, itsapplication as medicine preparing method and intermediate thereof and related compounds
04/07/2004CN1144804C Benzo[C] quinolizine derivatives and their use as 5 alpha-reductases inhibitors
04/07/2004CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same
04/07/2004CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines
04/07/2004CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition
04/07/2004CN1144581C Health giving bathing mud
04/07/2004CN1144578C Combination use of L-2-oxothiazolidine-4-carboxylic acid anjd polylol
04/06/2004US6716985 Alcoholism, psychological disorders
04/06/2004US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis
04/06/2004US6716871 Cyclic AMP-specific phosphodie sterase inhibitors
04/06/2004US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
04/06/2004US6716865 Benzoxa- and benzthiazoles
04/06/2004US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity
04/06/2004US6716847 Antiallergens, antiinflammatory
04/06/2004US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors.
04/06/2004US6716818 Caspase inhibitors and the use thereof
04/06/2004US6716441 Article comprising dispensing means with applied release composition including selected skin care active, release agent and barrier protectant; oleaginous, partially transferable to wearer's skin; contains ethoxylated c20-c40 fatty alcohol
04/06/2004US6716418 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
04/06/2004CA2404810C Topical composition having undifferentiated plant seed cells and method for using same
04/06/2004CA2299399C Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
04/06/2004CA2171294C Viscous surfactant emulsion compositions
04/06/2004CA2104515C Composition for accelerating healing of wound
04/06/2004CA2036592C Therapeutic agent for diabetic gangrene
04/01/2004WO2004027413A1 Method of screening antipruritic substance
04/01/2004WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative
04/01/2004WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
04/01/2004WO2004026871A1 Novel pyrazolopyridine derivatves as pharmaceutical agents
04/01/2004WO2004026844A1 Methods and compositions of novel triazine compounds
04/01/2004WO2004026842A1 Novel uracil derivatives and medicinal use thereof
04/01/2004WO2004026841A1 Novel 6-substituted uracil derivative and therapeutic agent for allergic disease
04/01/2004WO2004026835A1 Novel compound
04/01/2004WO2004026817A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant
04/01/2004WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors
04/01/2004WO2004026405A1 Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases
04/01/2004WO2004026335A1 Pharmaceutical composition comprising carriers for products
04/01/2004WO2004026324A1 Antiallergic agent and antiinflammatory agent
04/01/2004WO2004026317A1 Histamine release inhibitor
04/01/2004WO2004026297A1 Preparation for external use
04/01/2004WO2004026222A2 Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof
04/01/2004WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
04/01/2004WO2003104443A3 Hair follicle mesenchymal stem cells and use thereof
04/01/2004WO2003104402A3 Non-polymeric hematopoietic cell clots for delivery of active agents
04/01/2004WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/01/2004WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
04/01/2004WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
04/01/2004WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
04/01/2004WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function
04/01/2004WO2003097633A8 2-thio-substituted imidazole derivatives and their use in pharmaceutics
04/01/2004WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands
04/01/2004WO2003094864A3 Novel polyol-glycoside compositions for the skin
04/01/2004WO2003088927A3 Novel curcumin analogues and uses thereof
04/01/2004WO2003087220A3 Solid emulsions based on thermoplastic elastomers
04/01/2004WO2003086341A3 Aminophenylbenzothiazole compounds
04/01/2004WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
04/01/2004WO2003082777A3 Novel glucocorticoid receptor ligands
04/01/2004WO2003079963A3 Homeopathic modular complex
04/01/2004WO2003075953A3 Immunomodulatory polymeric antigens for treating inflammatory pathogies
04/01/2004WO2003075932A8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
04/01/2004WO2003075834A3 Activated protein c formulations
04/01/2004WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
04/01/2004WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects
04/01/2004WO2003060090A3 Novel cytokine zcytor17 ligand
04/01/2004WO2003028692A8 Acne treatment using oleanolic acid
04/01/2004WO2003009842A8 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
04/01/2004WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
04/01/2004WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7
04/01/2004WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/01/2004WO2002076402A3 Fatty amine drug conjugates
04/01/2004WO2002066480A3 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
04/01/2004WO2002064131A3 Inflammation-inhibiting compounds
04/01/2004US20040063946 Jnk inhibitor
04/01/2004US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
04/01/2004US20040063941 Novel spla2 inhibitors
04/01/2004US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
04/01/2004US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
04/01/2004US20040063781 Compounds active at the glucocorticoid receptor II
04/01/2004US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis
04/01/2004US20040063745 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
04/01/2004US20040063735 Calcitonin gene related peptide receptor antagonists
04/01/2004US20040063722 Antifungal ketoconazole composition for topical use
04/01/2004US20040063720 Tyrosine kinase inhibitors
04/01/2004US20040063709 Acute and chronic inflammatory disorders; cancer